Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, February 19, 2013

Osiris Therapeutics Receives Title of European Orphan Drug Designation for ProchymalA

Osiris Therapeutics, Inc. , the leading stem cell company developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that the European Medicines Agency has designated Osiris as the Orphan Drug title holder for ProchymalA .

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130219005870&newsLang=en&ndmConfigId=1000639&vnsId=41

No comments:

Post a Comment

Popular Stem Cell Roundup Posts